dx 9065 has been researched along with fidexaban in 3 studies
| Studies (dx 9065) | Trials (dx 9065) | Recent Studies (post-2010) (dx 9065) | Studies (fidexaban) | Trials (fidexaban) | Recent Studies (post-2010) (fidexaban) |
|---|---|---|---|---|---|
| 17 | 0 | 0 | 21 | 1 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dallas, JL; Guilford, WJ; Koovakkat, S; Lee, W; Liang, A; Light, DR; McCarrick, MA; Morrissey, MM; Shaw, KJ; Whitlow, M; Ye, B | 1 |
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
| Cheney, DL; Knabb, RM; Pinto, DJ; Smallheer, JM; Wexler, RR | 1 |
2 review(s) available for dx 9065 and fidexaban
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
Factor Xa inhibitors: next-generation antithrombotic agents.
Topics: Administration, Oral; Animals; Anticoagulants; Biological Availability; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Hemostasis; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Thrombosis | 2010 |
1 other study(ies) available for dx 9065 and fidexaban
| Article | Year |
|---|---|
Synthesis, characterization, and structure-activity relationships of amidine-substituted (bis)benzylidene-cycloketone olefin isomers as potent and selective factor Xa inhibitors.
Topics: Benzylidene Compounds; Factor Xa Inhibitors; Humans; Magnetic Resonance Spectroscopy; Serine Proteinase Inhibitors; Structure-Activity Relationship | 1999 |